Found: 7
Select item for more details and to access through your institution.
A Cost-Effectiveness Analysis of Adjuvant Nivolumab for Patients with Resected Esophageal Cancer or Gastroesophageal Junction Cancer in France.
- Published in:
- PharmacoEconomics - Open, 2024, v. 8, n. 5, p. 689, doi. 10.1007/s41669-024-00500-y
- By:
- Publication type:
- Article
Caregiver burden by treatment and clinical characteristics of patients with glioblastoma.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 2, p. 1365, doi. 10.1007/s00520-021-06514-0
- By:
- Publication type:
- Article
Correction to: Caregiver burden by treatment and clinical characteristics of patients with glioblastoma.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Pooled analysis of nivolumab treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck in the United States and Germany.
- Published in:
- Head & Neck, 2021, v. 43, n. 11, p. 3540, doi. 10.1002/hed.26853
- By:
- Publication type:
- Article
Real-World Treatment Patterns and Outcomes in Patients with Head and Neck Cancer: Point-in-Time Survey of Oncologists in Italy and Spain.
- Published in:
- Advances in Therapy, 2021, v. 38, n. 9, p. 4722, doi. 10.1007/s12325-021-01851-2
- By:
- Publication type:
- Article
Real-world study of the impact of recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) on quality of life and productivity in Europe.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Survival, costs, and health care resource use by line of therapy in US Medicare patients with newly diagnosed glioblastoma: a retrospective observational study.
- Published in:
- Neuro-Oncology Practice, 2020, v. 7, n. 2, p. 164, doi. 10.1093/nop/npz042
- By:
- Publication type:
- Article